Aurora Cannabis (ACB) Total Current Liabilities (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Total Current Liabilities of $48.8 million for Q1 2026, down 36.83% year-over-year from $77.3 million in Q1 2025, and down 36.83% quarter-over-quarter from $77.3 million in Q1 2025.
Aurora Cannabis (ACB) Total Current Liabilities (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Total Current Liabilities for 9 consecutive years, with $48.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 36.83% year-over-year to $48.8 million; the TTM figure through Mar 2026 stood at $48.8 million (down 36.83% YoY), while the FY2026 annual figure was $48.8 million, down 38.8% from the prior year.
- Total Current Liabilities retreated to $48.8 million in Q1 2026 per ACB's latest filing, from $77.3 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $175.9 million in Q1 2023 and bottomed at $48.8 million in Q1 2026.
- Historically, Total Current Liabilities has averaged $99.4 million across 5 years, with a median of $92.5 million in 2024.
- Annual changes were most pronounced in 2022 — Total Current Liabilities advanced 8.41% — and 2024, when it slumped 47.41%.
- Aurora Cannabis' Total Current Liabilities stood at $102.6 million in 2022, then jumped by 71.34% to $175.9 million in 2023, then plunged by 47.41% to $92.5 million in 2024, then retreated by 16.46% to $77.3 million in 2025, then slumped by 36.83% to $48.8 million in 2026.
- Business Quant data shows ACB's Total Current Liabilities at $48.8 million in Q1 2026, $77.3 million in Q1 2025, and $92.5 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.79 Bn |
| 10 | Aurora Cannabis | 233.30 Mn | 160.99 Mn | 25.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.81 Mn |
| Mar 31, 2025 | 77.26 Mn |
| Mar 31, 2024 | 92.48 Mn |
| Mar 31, 2023 | 175.85 Mn |
| Jun 30, 2022 | 102.64 Mn |
| Jun 30, 2021 | 94.67 Mn |
| Jun 30, 2020 | 196.35 Mn |
| Jun 30, 2019 | 326.14 Mn |
| Jun 30, 2018 | 58.26 Mn |